Stocks
Bristol-Myers (BMY) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 19.4 | 35.2 | 8.42 | 9.61 | 6.97 | 29.2 | ||
| Changes by years, y/y, % | +42% | +81% | -76% | +14% | -27% | -12.7% | |||
Bristol-Myers. EV/EBITDA
Bristol-Myers. EV/EBITDA, changes, %
Bristol-Myers (BMY) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 7.83 | 7.00 | 29.2 | 25.6 | 29.5 | 29.2 | |
| Changes by years, y/y, % | -12% | -22% | +240% | +207% | +276% | |||
| Changes by quarters, q/q, % | -6% | -11% | +317% | -12% | +15% | |||
